Want to see ANIK full AI Analyst Report?
Anika Therapeutics (ANIK) Income Statement
Anika Therapeutics Income Statement
Last quarter (Q2 2026), Anika Therapeutics's total revenue was $32.61M, an increase of 15.56% from the same quarter last year. In Q2, Anika Therapeutics's net income was $3.31M. See Anika Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 112.82M | $ 119.91M | $ 120.79M | $ 113.83M | $ 147.79M | |
| $ 63.81M | $ 76.00M | $ 82.53M | $ 73.22M | $ 82.94M | |
| $ 74.86M | $ 81.10M | $ 81.69M | $ 69.55M | $ 80.33M | |
| Depreciation and Amortization | $ 5.73M | $ 8.12M | $ 14.22M | $ 14.49M | $ 14.32M |
| $ -3.58M | $ 5.36M | $ 17.37M | $ 18.81M | $ -4.16M | |
| $ -11.05M | $ -5.10M | $ 844.00K | $ 3.67M | $ 2.62M | |
| $ 1.74M | $ 2.34M | $ 2.31M | $ 654.00K | $ -188.00K | |
| $ -9.31M | $ -2.76M | $ 3.16M | $ 4.32M | $ 2.43M | |
| $ -10.88M | $ -56.38M | $ -82.67M | $ -14.86M | $ 4.13M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.76 | $ -3.83 | $ -5.64 | $ -1.02 | $ 0.29 |
| Diluted EPS | $ -0.76 | $ -3.83 | $ -5.64 | $ -1.02 | $ 0.28 |
| Weighted Average Shares Outstanding | 14.34M | 14.72M | 14.66M | 14.56M | 14.40M |
| Weighted Average Shares Outstanding (Diluted) | 14.34M | 14.72M | 14.66M | 14.56M | 14.63M |
Currency in USD
